Acute erythroblastic leukemia terminating a very long-lasting (27 years) Hodgkin's disease.
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols; D005260:Female; D006689:Hodgkin Disease / Q000150:complications* / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D004915:Leukemia, Erythroblastic, Acute / Q000097:blood / Q000175:diagnosis / Q000209:etiology*; D008134:Long-Term Care; D008466:Mechlorethamine / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D011344:Procarbazine / Q000009:adverse effects / Q000627:therapeutic use; D011878:Radiotherapy / Q000009:adverse effects; D014750:Vincristine / Q000009:adverse effects / Q000627:therapeutic use
D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone